Search by Drug Name or NDC
NDC 00006-3516-59 PRIMAXIN 500; 500 mg/100mL; mg/100mL Details
PRIMAXIN 500; 500 mg/100mL; mg/100mL
PRIMAXIN is a INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is CILASTATIN SODIUM; IMIPENEM.
MedlinePlus Drug Summary
Imipenem and cilastatin injection is used to treat certain serious infections that are caused by bacteria, including endocarditis (infection of the heart lining and valves) and respiratory tract (including pneumonia), urinary tract, abdominal (stomach area), gynecological, blood, skin, bone, and joint infections. Imipenem is in a class of medications called carbapenem antibiotics. It works by killing bacteria. Cilastatin is in a class of medications called dehydropeptidase inhibitors. It works by helping imipenem stay active in your body for a longer period of time. Antibiotics such as imipenem and cilastatin injection will not work for colds, flu, or other viral infections. Taking antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 00006-3516-59Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Imipenem and Cilastatin Injection
Product Information
| NDC | 00006-3516 |
|---|---|
| Product ID | 0006-3516_32a4728f-dcf2-4008-9c8a-0706d2e1f97b |
| Associated GPIs | 16159902402120 |
| GCN Sequence Number | 009365 |
| GCN Sequence Number Description | imipenem/cilastatin sodium VIAL 500 MG INTRAVEN |
| HIC3 | W1S |
| HIC3 Description | CARBAPENEM ANTIBIOTICS (THIENAMYCINS) |
| GCN | 67651 |
| HICL Sequence Number | 004054 |
| HICL Sequence Number Description | IMIPENEM/CILASTATIN SODIUM |
| Brand/Generic | Brand |
| Proprietary Name | PRIMAXIN |
| Proprietary Name Suffix | IV |
| Non-Proprietary Name | imipenem and cilastatin sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 500; 500 |
| Active Ingredient Units | mg/100mL; mg/100mL |
| Substance Name | CILASTATIN SODIUM; IMIPENEM |
| Labeler Name | Merck Sharp & Dohme LLC |
| Pharmaceutical Class | Carbapenems [CS], Dipeptidase Inhibitors [MoA], Penem Antibacterial [EPC], Renal Dehydropeptidase Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA050587 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00006-3516-59 (00006351659)
| NDC Package Code | 0006-3516-59 |
|---|---|
| Billing NDC | 00006351659 |
| Package | 25 VIAL, SINGLE-DOSE in 1 TRAY (0006-3516-59) / 100 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 1985-11-26 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |